Glucagon-like Peptide-2 Receptor Activation Engages Bad and Glycogen Synthase Kinase-3 in a Protein Kinase A-dependent Manner and Prevents Apoptosis following Inhibition of Phosphatidylinositol 3-Kinase

This publication has 59 references indexed in Scilit:

• Minireview: The Glucagon-Like Peptides
  Endocrinology, 2001
• The Glucagon-like Peptide-2 Receptor Mediates Direct Inhibition of Cellular Apoptosis via a cAMP-dependent Protein Kinase-independent Pathway
  Journal of Biological Chemistry, 2000
• Insulinotropic glucagon-like peptide 1 agonists stimulate expression of homeodomain protein IDX-1 and increase islet size in mouse pancreas.
  Diabetes, 2000
• Exendin-4 stimulates both beta-cell replication and neogenesis, resulting in increased beta-cell mass and improved glucose tolerance in diabetic rats.
  Diabetes, 1999
• Effects of temperature on slow and fast inactivation of rat skeletal muscle Na⁺channels
  American Journal of Physiology-Cell Physiology, 1999
• Identification of Glucagon-like Peptide-2 (GLP-2)-activated Signaling Pathways in Baby Hamster Kidney Fibroblasts Expressing the Rat GLP-2 Receptor
  Published by Elsevier ,1999
• Regulation of the biological activity of glucagon-like peptide 2 in vivo by dipeptidyl peptidase IV
  Nature Biotechnology, 1997
• Induction of intestinal epithelial proliferation by glucagon-like peptide 2.
  Proceedings of the National Academy of Sciences, 1996
• A simple assay for examining the effect of transiently expressed genes on programmed cell death
  Journal of Immunological Methods, 1995
• Lack of Glucagon Response to Hypoglycemia in Diabetes: Evidence for an Intrinsic Pancreatic Alpha Cell Defect
  Science, 1973